Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel

MLA

Zhan Yang, et al. “Silencing of MiR-193a-5p Increases the Chemosensitivity of Prostate Cancer Cells to Docetaxel.” Journal of Experimental & Clinical Cancer Research, vol. 36, no. 1, Dec. 2017, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s13046-017-0649-3.

APA

Zhan Yang, Jin-Suo Chen, Jin-Kun Wen, Hai-Tao Gao, Bin Zheng, Chang-Bao Qu, Kai-Long Liu, Man-Li Zhang, Jun-Fei Gu, Jing-Dong Li, Yan-Ping Zhang, Wei Li, Xiao-Lu Wang, & Yong Zhang. (2017). Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel. Journal of Experimental & Clinical Cancer Research, 36(1), 1–15. https://doi.org/10.1186/s13046-017-0649-3

Chicago

Zhan Yang, Jin-Suo Chen, Jin-Kun Wen, Hai-Tao Gao, Bin Zheng, Chang-Bao Qu, Kai-Long Liu, et al. 2017. “Silencing of MiR-193a-5p Increases the Chemosensitivity of Prostate Cancer Cells to Docetaxel.” Journal of Experimental & Clinical Cancer Research 36 (1): 1–15. doi:10.1186/s13046-017-0649-3.